Medifast, Inc. (MED) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Medifast, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -6.28x | 92.10x | 7.36x | 8.99x | 14.94x | 22.47x |
| P/B Ratio | 0.59x | 0.92x | 3.63x | 8.33x | 12.11x | 14.70x |
| P/S Ratio | 0.30x | 0.32x | 0.68x | 0.81x | 1.61x | 2.47x |
| Profitability | ||||||
| Gross Margin | 71.3% | 73.8% | 72.4% | 71.3% | 73.9% | 74.6% |
| Operating Margin | -3.7% | 0.5% | 11.8% | 11.6% | 14.2% | 14.4% |
| Net Margin | -4.8% | 0.3% | 9.3% | 9.0% | 10.7% | 11.0% |
| EBITDA Margin | -1.0% | 2.6% | 13.0% | 12.2% | 14.6% | 14.8% |
| Liquidity | ||||||
| Current Ratio | 4.69x | 3.34x | 2.43x | 1.58x | 1.81x | 2.10x |
| Quick Ratio | 4.22x | 2.68x | 1.84x | 0.74x | 0.75x | 1.62x |
| Leverage | ||||||
| Debt/Equity | 0.08x | 0.08x | 0.11x | 0.17x | 0.16x | 0.07x |
YoY = year-over-year change. Source: FMP..